TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33919721

Group type: EXPERIMENTAL
Intervention: Importance of tribal identity
Number of subjects: 579

Group type: EXPERIMENTAL
Intervention: Tribal language proficiency
Number of subjects: 579
Study: 34955484

Group type: EXPERIMENTAL
Intervention: Fluoridated BRP dentifrice
Number of subjects: 42

Group type: COMPARATOR
Intervention: Fluoridated common dentifrice
Number of subjects: 42
Study: 32087745

Group type: EXPERIMENTAL
Intervention: Person-centred approach in the trial
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Person-centred processes including home visits and assistance with questionnaires
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Trial processes and intervention
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Adverse effects
Number of subjects: 64
Study: 33332873

Group type: EXPERIMENTAL
Intervention: Open synthetic mesh
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Open biological mesh
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Laparoscopic synthetic mesh
Number of subjects: 253

Group type: EXPERIMENTAL
Intervention: Laparoscopic biological mesh
Number of subjects: 253

Group type: COMPARATOR
Intervention: Biological mesh (overall)
Number of subjects: 253
Study: 32315965

Group type: EXPERIMENTAL
Intervention: Baduanjin exercise
Number of subjects: 61

Group type: COMPARATOR
Intervention: Brisk walking
Number of subjects: 61
Study: 35531961

Group type: EXPERIMENTAL
Intervention: Newborn Behavioral Observations (NBO) plus treatment as usual (TAU)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Treatment as usual (TAU) only
Number of subjects: 74
Study: 34898918

Group type: EXPERIMENTAL
Intervention: 0.4% Triphala mouthwash
Number of subjects: 72

Group type: COMPARATOR
Intervention: 0.12% chlorhexidine mouthwash
Number of subjects: 72
Study: 34910093

Group type: EXPERIMENTAL
Intervention: HYPE + CAT
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: HYPE + befriending
Number of subjects: 139

Group type: COMPARATOR
Intervention: YMHS + befriending
Number of subjects: 139

Group type: COMPARATOR
Intervention: HYPE + CAT vs befriending
Number of subjects: 139

Group type: COMPARATOR
Intervention: HYPE vs YMHS + befriending
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 139
Study: 34728746

Group type: EXPERIMENTAL
Intervention: Wearable device
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Smartphone
Number of subjects: 0
Study: 35421875

Group type: EXPERIMENTAL
Intervention: Zheng‐Yi‐Fang (ZYF)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Regular western medicine (Control)
Number of subjects: 0
Study: 33990249

Group type: EXPERIMENTAL
Intervention: Cognitive Processing Therapy (CPT)
Number of subjects: 188
Study: 32845329

Group type: COMPARATOR
Intervention: NIH or US government agency-sponsored trials
Number of subjects: 245999

Group type: COMPARATOR
Intervention: Industry-sponsored trials
Number of subjects: 245999

Group type: COMPARATOR
Intervention: Other sources-sponsored trials
Number of subjects: 245999
Study: 616122612

Group type: EXPERIMENTAL
Intervention: Melatonin 3 mg t.i.d for 1 month
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 36155516

Group type: EXPERIMENTAL
Intervention: Cerebrolysin®
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Donepezil
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Combination therapy
Number of subjects: 116

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 116
Study: 33501510

Group type: EXPERIMENTAL
Intervention: Dominant hand
Number of subjects: 60

Group type: COMPARATOR
Intervention: Non-dominant hand
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both hands
Number of subjects: 60
Study: 32101857

Group type: EXPERIMENTAL
Intervention: Combined high-intensity interval training (2-week duration)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine lifestyle (control group)
Number of subjects: 0
Study: 35882451

Group type: EXPERIMENTAL
Intervention: 12 individual biobehaviourally informed, app‐facilitated, multicomponent telerehabilitation sessions with a licenced physical therapist (n=29)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Education on exercise and COVID‐19 recovery trajectory, physical activity and vitals monitoring, and weekly check‐ins with study staff (n=15)
Number of subjects: 44
Study: 33402333

Group type: EXPERIMENTAL
Intervention: Increase in the number of RCTs by 5% for each 10% increase in disability-adjusted life years (DALYs) for a health condition (3.2%-6.9%).
Number of subjects: 463000

Group type: EXPERIMENTAL
Intervention: Conditions like respiratory infections and tuberculosis had 7000 RCTs below predicted numbers based on disease burden.
Number of subjects: 463000

Group type: EXPERIMENTAL
Intervention: Each 10% shift in DALYs towards low and middle socioeconomic development countries was associated with a 4% reduction in RCTs (3.7%-4.9%).
Number of subjects: 463000
Study: 36057478

Group type: EXPERIMENTAL
Intervention: Rocabado's 6 × 6 exercises
Number of subjects: 58

Group type: COMPARATOR
Intervention: Self-care program
Number of subjects: 58
Study: 33546748

Group type: EXPERIMENTAL
Intervention: 650-nm invasive laser acupuncture (ILA)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 830-nm invasive laser acupuncture (ILA)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Real electroacupuncture (EA)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Korean version of the Oswestry Disability Index
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: European Quality of Life Five Dimension Five Level scale
Number of subjects: 45
Study: 35320216

Group type: EXPERIMENTAL
Intervention: Virtual Reality exercises with routine physical therapy
Number of subjects: 84

Group type: COMPARATOR
Intervention: Routine physical therapy
Number of subjects: 84
Study: 32657136

Group type: EXPERIMENTAL
Intervention: PrEP (Pre-Exposure Prophylaxis)
Number of subjects: 370
Study: 36344629

Group type: EXPERIMENTAL
Intervention: Combination therapy of mirabegron and solifenacin
Number of subjects: 219

Group type: COMPARATOR
Intervention: Solifenacin therapy (Control)
Number of subjects: 219
Study: 32366577

Group type: EXPERIMENTAL
Intervention: Intensive systolic blood pressure (SBP) lowering (<120 mmHg) in the standard glycemic control arm
Number of subjects: 4731

Group type: EXPERIMENTAL
Intervention: Intensive systolic blood pressure (SBP) lowering (<120 mmHg) in the intensive glycemic control arm
Number of subjects: 4731

Group type: COMPARATOR
Intervention: Standard glycemic control
Number of subjects: 4731

Group type: COMPARATOR
Intervention: Intensive glycemic control
Number of subjects: 4731
Study: 35044166

Group type: EXPERIMENTAL
Intervention: Allergen-alone exposure
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: DE and allergen coexposure
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Coexposure with particle-reducing technology
Number of subjects: 14

Group type: COMPARATOR
Intervention: Negative control
Number of subjects: 14
Study: 33906634

Group type: EXPERIMENTAL
Intervention: Mucinous tumors with mucus extension
Number of subjects: 152

Group type: COMPARATOR
Intervention: Non-mucinous tumors
Number of subjects: 152
Study: 32282706

Group type: EXPERIMENTAL
Intervention: Best standard of care plus cytokine adsorption during surgery while on cardiopulmonary bypass (protocol A)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Best standard of care alone, surgery without cytokine adsorption (protocol B)
Number of subjects: 54
Study: 35849476

Group type: EXPERIMENTAL
Intervention: relugolix-combination therapy (relugolix-CT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study: 34746417

Group type: EXPERIMENTAL
Intervention: PB-NHESC-C (autologous peripheral blood non-hematopoietic enriched stem cell cocktail)
Number of subjects: 139

Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 139

Group type: EXPERIMENTAL
Intervention: PB-NHESC-C
Number of subjects: 139
Study: 33038408

Group type: EXPERIMENTAL
Intervention: Autonomic regulation therapy (ART) utilizing cervical vagus nerve stimulation (VNS) for 6 months post-titration
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Autonomic regulation therapy (ART) utilizing cervical vagus nerve stimulation (VNS)
Number of subjects: 60
Study: 35799657

Group type: EXPERIMENTAL
Intervention: 2 times ED95 cis-atracurium (S1 group, 30 cases)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 3 times ED95 cis-atracurium (S2 group, 30 cases)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 4 times ED95 cis-atracurium (S3 group, 30 cases)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 3 times ED95 cis-atracurium (S2 group)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 4 times ED95 cis-atracurium (S3 group)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 3 times ED95 cis-atracurium
Number of subjects: 90
Study: 32990858

Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) injections
Number of subjects: 44

Group type: COMPARATOR
Intervention: Saline solution (placebo) injections
Number of subjects: 44
Study: 36286317

Group type: EXPERIMENTAL
Intervention: Pressure-Support Ventilation (PSV)
Number of subjects: 969

Group type: COMPARATOR
Intervention: T-Piece
Number of subjects: 969
Study: 32380290

Group type: EXPERIMENTAL
Intervention: Pulsed Field Ablation (PFA)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Radiofrequency Ablation (RFA)
Number of subjects: 80
Study: 36273168

Group type: EXPERIMENTAL
Intervention: Metformin (MET)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Acarbose (ACA)
Number of subjects: 104
Study: 34366347

Group type: EXPERIMENTAL
Intervention: Active high-definition transcranial direct current stimulation (HD-tDCS)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Sham high-definition transcranial direct current stimulation (HD-tDCS)
Number of subjects: 19
Study: 35536390

Group type: EXPERIMENTAL
Intervention: Patient-assisted compression (PAC)
Number of subjects: 448

Group type: COMPARATOR
Intervention: Standard compression (SC)
Number of subjects: 448
Study: 34284317

Group type: EXPERIMENTAL
Intervention: Real air purification
Number of subjects: 57

Group type: COMPARATOR
Intervention: Sham air purification
Number of subjects: 57
Study: 35517991

Group type: EXPERIMENTAL
Intervention: Magnetic ureteric stenting retrieval device
Number of subjects: 333

Group type: COMPARATOR
Intervention: Conventional ureteral stent
Number of subjects: 333
Study: 32662374

Group type: EXPERIMENTAL
Intervention: Attachment and Biobehavioral Catch‐up (ABC) intervention
Number of subjects: 200

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 200
Study: 32882517

Group type: EXPERIMENTAL
Intervention: GEAR
Number of subjects: 19

Group type: COMPARATOR
Intervention: Treadmill
Number of subjects: 19
Study: 35354280

Group type: EXPERIMENTAL
Intervention: sintilimab + pemetrexed + platinum (SPP)
Number of subjects: 557

Group type: COMPARATOR
Intervention: placebo + pemetrexed + platinum (PPP)
Number of subjects: 557
Study: 33795299

Group type: EXPERIMENTAL
Intervention: Biological mesh repair
Number of subjects: 140

Group type: COMPARATOR
Intervention: Primary perineal wound closure
Number of subjects: 140
Study: 33210178

Group type: EXPERIMENTAL
Intervention: Apremilast (in vivo administration)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control MSCs (C-MSCs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PsO-MSCs T0 (before treatment)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PsO-MSCs T12 (after treatment)
Number of subjects: 0
Study: 32210231

Group type: EXPERIMENTAL
Intervention: Genetic association with earlier male puberty timing
Number of subjects: 205354

Group type: EXPERIMENTAL
Intervention: Mendelian randomization analyses
Number of subjects: 205354

Group type: EXPERIMENTAL
Intervention: Genomic correlation analysis
Number of subjects: 205354

Group type: EXPERIMENTAL
Intervention: Identification of independent signals
Number of subjects: 205354

Group type: EXPERIMENTAL
Intervention: Link between puberty timing and natural hair colour
Number of subjects: 205354
Study: 33686446

Group type: EXPERIMENTAL
Intervention: Fractional laser-assisted topical corticosteroid delivery
Number of subjects: 19

Group type: COMPARATOR
Intervention: Fractional laser monotherapy
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 19
Study: 33028554

Group type: EXPERIMENTAL
Intervention: IV contrast-enhanced CT
Number of subjects: 994

Group type: COMPARATOR
Intervention: Native CT
Number of subjects: 994
Study: 35842282

Group type: EXPERIMENTAL
Intervention: Biofunctional Prosthetic System (BPS) complete dentures
Number of subjects: 16

Group type: COMPARATOR
Intervention: Conventional complete dentures
Number of subjects: 16
Study: 33691056

Group type: EXPERIMENTAL
Intervention: Lidocaine 2% (1 mL)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Granisetron (1 mg in 1 mL)
Number of subjects: 40
Study: 32495646

Group type: EXPERIMENTAL
Intervention: MPTP + Environmental Enrichment (EE)
Number of subjects: 42
Study: 34931854

Group type: EXPERIMENTAL
Intervention: Infographic
Number of subjects: 159

Group type: EXPERIMENTAL
Intervention: Written summary
Number of subjects: 159

Group type: COMPARATOR
Intervention: Video animation
Number of subjects: 159
Study: 32306525

Group type: EXPERIMENTAL
Intervention: HSF™-based skin care formulation
Number of subjects: 32
Study: 35569575

Group type: EXPERIMENTAL
Intervention: Attention Bias Modification (ABM)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control
Number of subjects: 61
Study: 32234533

Group type: EXPERIMENTAL
Intervention: Entrée portion sizes reduced to 90%, 85%, 80%, and 75% of the initial amount consumed in the first week.
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Entrée portion sizes at 80% and 75% reductions.
Number of subjects: 81
Study: 32545143

Group type: EXPERIMENTAL
Intervention: Moringa leaf extract and iron capsules
Number of subjects: 40

Group type: COMPARATOR
Intervention: Iron capsules
Number of subjects: 40
Study: 34182233

Group type: EXPERIMENTAL
Intervention: Anodal HD-tDCS targeting the pDMN
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Cathodal HD-tDCS targeting the aDMN
Number of subjects: 84

Group type: COMPARATOR
Intervention: Sham HD-tDCS (Control)
Number of subjects: 84
Study: 35216783

Group type: EXPERIMENTAL
Intervention: Home-based neurofunctional training (HBNFT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Home-based resistance training (HBRT)
Number of subjects: 30
Study: 33624731

Group type: EXPERIMENTAL
Intervention: WeChat-based education and rehabilitation program (WERP)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control care (CC)
Number of subjects: 140
Study: 34425725

Group type: EXPERIMENTAL
Intervention: 4-minute instructional video alone
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: 4-minute instructional video with video reflection intervention
Number of subjects: 62
Study: 33997885

Group type: EXPERIMENTAL
Intervention: Dexamethasone suppression test (DST) with method-specific cortisol cutoff of 2.4 µg/dL
Number of subjects: 400

Group type: COMPARATOR
Intervention: Dexamethasone suppression test (DST) without method-specific cortisol cutoff
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Dexamethasone <1.8 ng/mL in AI-ACS samples
Number of subjects: 400
Study: 32310989

Group type: EXPERIMENTAL
Intervention: Stackelberg Game Theoretical Model for Load Balancing (SGMLB) algorithm
Number of subjects: 0
Study: 35078116

Group type: EXPERIMENTAL
Intervention: Perampanel (maximum dose: 12 mg/day)
Number of subjects: 97
Study: 34004422

Group type: EXPERIMENTAL
Intervention: Integrated collaborative care intervention (I‐CARE)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 108
Study: 35482347

Group type: EXPERIMENTAL
Intervention: Experimental agent (cancer drug)
Number of subjects: 24806

Group type: EXPERIMENTAL
Intervention: Targeted drugs
Number of subjects: 24806

Group type: EXPERIMENTAL
Intervention: Immunotherapy drugs
Number of subjects: 24806

Group type: EXPERIMENTAL
Intervention: Non-immunotherapy-targeted drugs
Number of subjects: 24806

Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 24806
Study: 33325793

Group type: EXPERIMENTAL
Intervention: Intravitreal dexamethasone (IVD) implant
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (no IVD implant)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Both groups (IVD and control)
Number of subjects: 52
Study: 34286526

Group type: EXPERIMENTAL
Intervention: New health education pathway for echinococcosis control
Number of subjects: 975

Group type: COMPARATOR
Intervention: Routine health education (Control)
Number of subjects: 975
Study: 33091102

Group type: EXPERIMENTAL
Intervention: Monthly audits of all ADC pockets
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Monthly audits of matrix (open pocket) drawers only
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Monthly audits of unassigned pockets only
Number of subjects: 4

Group type: COMPARATOR
Intervention: No additional intervention
Number of subjects: 4
Study: 36459910

Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PTB) applied at pain points (G2) with a dose of 4 J and 6 J.
Number of subjects: 54

Group type: COMPARATOR
Intervention: Photobiomodulation therapy (PTB) applied at pre-established points (G1) with a dose of 4 J and 6 J.
Number of subjects: 54
Study: 34831764

Group type: EXPERIMENTAL
Intervention: Small-sided games (SSGs) training program during Ramadan intermitting fasting (RIF), 4 weeks, 3 sessions per week
Number of subjects: 24

Group type: COMPARATOR
Intervention: Active control group (CON), same SSG training program
Number of subjects: 24
Study: 35014162

Group type: EXPERIMENTAL
Intervention: Deep neuromuscular blockade
Number of subjects: 38

Group type: COMPARATOR
Intervention: Moderate neuromuscular blockade
Number of subjects: 38
Study: 33538902

Group type: EXPERIMENTAL
Intervention: Increased blood pressure to 150 mmHg for 5 min using norepinephrine pump (0.05 μg/kg/min initial dose) after specimen extraction during ESD
Number of subjects: 309

Group type: COMPARATOR
Intervention: Normal ESD
Number of subjects: 309
Study: 34312043

Group type: EXPERIMENTAL
Intervention: SCT+HE (Standard Conservative Therapy plus Home Exercise)
Number of subjects: 0

Group type: COMPARATOR
Intervention: SCT (Standard Conservative Therapy)
Number of subjects: 0
Study: 32012958

Group type: EXPERIMENTAL
Intervention: Gait retraining + minimalist shoe (GR)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Minimalist shoe (MIN)
Number of subjects: 30
Study: 34352387

Group type: EXPERIMENTAL
Intervention: Standardized diet
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Personalized feedback
Number of subjects: 135
Study: 32603281

Group type: EXPERIMENTAL
Intervention: Minimally invasive surgical therapies (MISTs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medical treatment (drugs)
Number of subjects: 0
Study: 35189848

Group type: EXPERIMENTAL
Intervention: Group self-management support (10 weekly 2.5-hour group web-based sessions with 10-15 patients and two trained facilitators)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Group self-management support
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment-as-usual
Number of subjects: 0
Study: 34133958

Group type: EXPERIMENTAL
Intervention: DL‐PDT + CO2 laser
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: DL‐PDT + microdermabrasion
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Standard DL‐PDT
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: DL‐PDT + microneedles
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (Standard DL‐PDT)
Number of subjects: 40
Study: 36470757

Group type: EXPERIMENTAL
Intervention: Social media-based drama therapy
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Social media-based art therapy
Number of subjects: 330

Group type: EXPERIMENTAL
Intervention: Social media-based music therapy
Number of subjects: 330

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 330
Study: 34461035

Group type: EXPERIMENTAL
Intervention: Intervention (STAMP intervention): Brief telephone or web-based assessment generating a mailed, individually tailored feedback report with a stage-matched brochure at baseline, 2 months, and 4 months.
Number of subjects: 909

Group type: COMPARATOR
Intervention: Usual care (Control group):
Number of subjects: 909

Group type: EXPERIMENTAL
Intervention: Intervention (STAMP intervention):
Number of subjects: 909
Study: 32615357

Group type: EXPERIMENTAL
Intervention: Stepwise salt supply control (SSSC) with salt substitute (SS)
Number of subjects: 1606

Group type: COMPARATOR
Intervention: Stepwise salt supply control (SSSC) only
Number of subjects: 1606

Group type: COMPARATOR
Intervention: Salt substitute (SS) only
Number of subjects: 1606

Group type: COMPARATOR
Intervention: Neither SSSC nor SS
Number of subjects: 1606

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 1606
Study: 33588630

Group type: EXPERIMENTAL
Intervention: Diet soda
Number of subjects: 0

Group type: COMPARATOR
Intervention: Carbonated water
Number of subjects: 0

Group type: COMPARATOR
Intervention: Regular soda
Number of subjects: 0
Study: 32562324

Group type: EXPERIMENTAL
Intervention: Monolithic zirconia crown (Mono‐ZrO2)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Porcelain-fused-to-metal (PFM) crown
Number of subjects: 76
Study: 35393218

Group type: EXPERIMENTAL
Intervention: Full 90-minute HBOT dose in a pressurized chamber with 100% oxygen at 2.0 ATA
Number of subjects: 8

Group type: COMPARATOR
Intervention: Sham condition receiving 21% oxygen at a minimal pressure of ≤1.3 ATA
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Full 90-minute HBOT dose
Number of subjects: 8

Group type: COMPARATOR
Intervention: Sham condition
Number of subjects: 8
Study: 33778908

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT) three times per week for 6 months
Number of subjects: 65

Group type: COMPARATOR
Intervention: Control (non-intervention)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 65
Study: 32985114

Group type: EXPERIMENTAL
Intervention: Behavioral Weight Loss (BWL)
Number of subjects: 191

Group type: COMPARATOR
Intervention: Stepped Care
Number of subjects: 191
Study: 33098411

Group type: EXPERIMENTAL
Intervention: Atorvastatin (80 mg once daily)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 33891380

Group type: EXPERIMENTAL
Intervention: Bimekizumab (320 mg subcutaneously every 4 weeks)
Number of subjects: 743

Group type: COMPARATOR
Intervention: Secukinumab (300 mg subcutaneously weekly to week 4, then every 4 weeks)
Number of subjects: 743

Group type: EXPERIMENTAL
Intervention: Bimekizumab
Number of subjects: 743

Group type: COMPARATOR
Intervention: Secukinumab
Number of subjects: 743